certain
-
Biologics
Asterias Biotherapeutics Extends the Expiration Date of Certain Warrants and Provides Update on Cash Position
FREMONT, Calif., Feb. 3, 2017 /PRNewswire/ — Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company pioneering the field of regenerative…
Read More » -
Hospitals
FDA Extends UDI Compliance for Certain Class II Devices
By Michael Mezher – September 7, 2016 The US Food and Drug Administration (FDA) is giving medical device labelers two…
Read More » -
Hospitals
MiMedx Reaches Settlement With Medline Industries And Liventa Bioscience For Certain Claims
MARIETTA, Ga., June 21, 2016 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic…
Read More »